Chronic Malignancies Working Party (CMWP)
Study type:
Study number:
42207729
Type of Stem Cell Treatment:
Diseases:
Complications: non-infectious
Short title:
Primary objective:
Key inclusion criteria:
Diagnosis of dry eyes (with onset of >3 months) after allo-tx and eye symptom score >=2 for at least 2 months since last adjustment in topical lubricants prescription. Availability of an ophtalmologist with experience in punctual occlusion
Country:
Principal investigator:
Michel van Gelder
EBMT Study coordinator:
Jennifer Hoek